✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals

Arvee Laboratories (India) Ltd.

ARVEE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹193 Cr.
P/E
89.74

Arvee Laboratories (India) Ltd.

  • Arvee Laboratories
  • Kanchi Karpooram
  • Chemcrux Enterprises
FAQs on Arvee Laboratories (India) Ltd. Shareprice

Arvee Laboratories has given better returns compared to its competitors.
Arvee Laboratories has grown at ~-5.49% over the last 1yrs while peers have grown at a median rate of -14.82%

Yes, Arvee Laboratories is expensive.
Latest PE of Arvee Laboratories is 86.78, while 3 year average PE is 71.59.
Also latest EV/EBITDA of Arvee Laboratories is 50.13 while 3yr average is 29.3.

View FAQ's On Business
Growth Table
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Balance Sheet
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Cash Flow
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Quarterly Results
  • Arvee Laboratories (India) Ltd.
  • Kanchi Karpooram
  • Chemcrux Enterprises
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Arvee Laboratories (India) Ltd. Financials

Balance sheet of Arvee Laboratories is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Arvee Laboratories is decreasing.
Latest net debt of Arvee Laboratories is -₹4.94 Crs as of Mar-25.
This is less than Mar-24 when it was -₹2.61 Crs.

The profit is oscillating.
The profit of Arvee Laboratories is ₹2.15 Crs for TTM, ₹1.05 Crs for Mar 2024 and ₹4.12 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Arvee Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech